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801 FO-3 Determination of Mitral Annular 3-D Geometry From 
Real-Time 3-D Echocardiography: An In-Vitro Validation 
and Clinical Study 
because balloon stretch deformation transforms an asymmterical, ASD into an uniform 
shaped defect with a smaller maximal fluoroscopic BSD.Thus, 3DE TEE USD represents 
the best method to measure maximal diameter in asymmetrical ASDs 
Giuseppe Saracino, Takahiro Shiota, Qin Jian Xin Qin, Neil Greenberg. James D. 
Thomas, The Cleveland Clinic Foundation, Cleveland, OH 
The 3D geometry of mitral annulus (MA) is known to be related to valve function. Real- 
time 3D echocardiography (RT3DE) potentially enables noninvasive evaluation of annu- 
lar geometry. In this study, we propose a novel semi-automatic method for the assess- 
ment of MA geometry and apply this technique to examine differences between normal 
and prolapsing valves. Methods: Five saddle shaped MA phantoms with known angles 
(a: 65 to 160’) between the vectors from septal (S) and lateral (L) points to the center of 
the inter-commisural line (see figure) were imaged by RTSDE. Eight annular points were 
identified manually using customized visualization and analysis software. The shape of 
the MA phantom was reconstructed using an automated algorithm based on Fourier 
analysis and parameters including the angle, CI, were automatically derived. This tech- 
nique was applied in six normal subjects and in six patients with mitral valve prolapse 
(MVP) and severe mitral regurgitation. Results: A strong relationship between the esti- 
mated and actual angle of the MA phantoms studied in vitro was observed (y=O.99x+l.S, 
r=O.67, p<O.OOl). In the clinical study, the MA angle in MVP patients was significantly 
larger than for normals (143+5.6 vs 126+3.5”, p<O.O5). Time required to process the 
RTJDE data and obtain the angle was less than a minute. Conclusion: This new com- 
puterized semi-automatic method can determine unique 3D descriptors of MA geometry 
that may provide information about pathophysiologic changes in patients with MVP. 801 FO-5 Initial Experience With a New Real-Time 3-D Ultrasound 
Imager: Comparison With Conventional 
Echocardiographic Methods 
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801 FO-4 Comparison of 2-D Intracardiac and Transesophageal 
Echocardiography and Fluoroscopy to 3-D 
Echocardiography in Sizing Atrial Septal Defect for 
Percutaneous Device Closure 
Zheng Liu, Satish Surabhi, Bassam Roukoz, Tammana Nahar, Timothy Puri, Sheldon 
Goldberg, Mani A. Vannan, Daniel McCormick, Drexel University College of Medicine, 
Philadelphia, PA 
Background: Sizing Atrial Septal Defects (ASD) is essential for the selection of optimal 
Amplatzer occlusion device (AOD) during percutaneous closure. We compared the ASD 
diameter by transesophageal echo (TEE), intracardiac echo (ICE) and fluoroscopy to 
maximal 3-D Echo dimension of ASDs. 
Methods: 16 patients with secundum ASD underwent AOD closure. 2-D TEE and maxi- 
mal 3-D TEE (Fig. 1C) unstretched diameter (USD) were measured. During the AOD clo- 
sure, ICE USD and balloon stretched diameter (BSD) by both ICE (Fig. IA) and 
fluoroscopy (Fig. 1B) were measured. Results (mm, mean&D) were: 3-D TEE USD 
(21.4*7.2), fluoroscopic BSD (16.2e7.2). ICE BSD (17.7+6.3). ICE USD (13.2i6.5) and 
2-D TEE USD (12.5e7.9). 3-D TEE USD was marginally larger than fluoroscopic BSD 
(p=O.O42) and significantly larger than ICE BSD, ICE USD and 2-D TEE (p<O.OOl). Fluo- 
roscopic BSD was not significantly different from ICE BSD (p=O.16). Also, fluoroscopic 
BSD correlated well with ICE BSD and 3-D TEE (r=0.96 for both). In 2 cases where 3-DE 
USD was 4-6 mm larger than fluoroscopic BSD, the defects were irregular and non-uni- 
form (Fig. 2A-2C). 
Conclusions: ICE and fluoroscopy are compaiable in sizing symmterical ASDs. But flu- 
oroscopy may not yield the largest diameter in non-uniform and complex ASDs This is 
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Kumiko Hirata, Yumiko Miyake, Kenichi Sugioka, Marco Di Tullio, Shunnichi Homma. 
Shunnichi Homma, Columbia University. New York, NY 
Background: The aim of this study was to explore the clinical value of a newly devel- 
oped transthoracic real-time 3.dimensional (RT3D) echocardiography compared with 
conventional transthoracic and transesophageal echocardiography. This is the first ever 
report of clinical use of this new modality. Methods: We examined 22 patients (3 myo- 
cardial infarction, 13 mitral regurgitation, 2 mitral stenosis, 2 aortic stenosis and 2 aorlic 
regurgitation) using RTBD as well as with conventional transthoraclc, and transesoph- 
ageal echocardiography (All from Phillips Medical Systems, Andover, Mass.). We evalu- 
ated left ventricular wall motion, am-tic valve and mitral apparatus. These structures were 
all contained within the ?.ame 3D volume and displayed in a BD-rendered format in real- 
time that could be manipulated to demonstrate any plane within this volume. Results: In 
patients with myocardial Infarction, the estimation of wall motion abnormality from RTBD 
showed excellent concordance with those seen by the conventional methods. In patients 
with mitral valve disease, RTBD provided an accurate information regarding prolapsed 
portion, calcified lesion and malcoaptatlon points. Images were significantly easier to 
interpret compared to the conventional methods. However, in patients with aortic valve 
diseases, it was not always possible to obtain adequate images for evaluation of its ana- 
tomical features. Conclusions: New RTBD echocardiography provides accurate infor- 
mation regarding ventricular wall motion, and appears to be especially promising for 
evaluation of mitral valvular morphology. 
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802-l Noninvasive Assessment of Angiogenesis by Contrast 
Ultrasound Imaging With Microbubbles Targeted to 
Alpha-V lntegrins 
Howard Leona-Poi, Jonathan P. Christiansen, Alexander L. Klibanov, Sanjiv Kaul, 
Jonathan Ft. Lindner, University of Virginia, Charlottesville, VA 
Non-invasive methods for assessing angiogenesis in ischemic tissues are lacking. We 
hypothesized angiogenesls in tschemic tissues could be assessed using contrast- 
enhanced ultrasound (CEU) with microbubbles targeted for endothelial a,,-integrins 
expressed in neovessels. 
Microbubbles targeted to a, integtins (M&) were prepared by conjugating the dislntegrin 
echistatin to their surface. lntravital microscopy revealed retention of MB E but not control 
microbubbles to FGF-P-treated cremaster muscles. Preferential retention of MB, 
microbubbles was also found during CEU imaging of a matrigel plug model of angiogen- 
esns in mice. The ability to assess angiogenic responses to chronic &hernia with q-tar- 
geted microbubbles was tested in an ischemic hindlimb model produced by common iliac 
artery ligation in 16 rats. The proximal adductor muscles of the ischemic and contralat- 
eral control hindlimb were studied at 1 hr (in all animals), and at 4, 7, 14, and 26 days 
(n=4 for each). CEU perfusion imaging with non-targeted microbubbles, and targeted 
imaging of angiogenws with MB, were performed. Tissue PQ was measured by phos- 
phorescence quenching. One hour after ligation, the normalized mtcrova?.cular blood 
flow (0.31*0.11) and microvascular blood volume (0.5&0.13) for the ischemic muscle 
were low. M& signal intensity in lschemlc muscle, normakzed to mlcrovascular blood 
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flow, was mildly increased at 1 hr (2.0+2.3), then increased over the first week peaking at 
day 4 (5.6+2.6), then declined rapidly (0.950.7 at day 26). The MB, Signal peak pre- 
ceded increases in normalized blood flow and blood volume, were not detected until after 
day 14 (0.52+0.11 and 0.87*0.09, for blood flow and volume at 28 days). MB, Signal 
peak also preceded an increase in ischemic muscle tissue PO, (normalized values Of 
0.24+0.06 and 0.47+0.10, at 1 hr and 28 days, respectively). 
We conclude that CEU with microbubbles targeted for endothelial a,-in&grins can be 
used to non-invasively assess anglogenic responses in skeletal muscle. These results 
suggest that targeted CEU imaging of endothelial markers of angiogenesis may poten- 
tially be used for assessing intrinsic and therapeutic angiogenesis prior to changes tn 
perfusion. 
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802-4 Site-Specific Imaging of Tumor Angiogenesis Using 
Contrast-Enhanced Ultrasound Imaging With 
Microbubbles Targeted to Alpha-V Beta-3 
Howard Leono-Poi, Dilantha Ellegala, Joan Carpenter, Alexander L. Klibanov, Vu Duong, 
Sanjiv Kaul, Mark E. Shaffrey, Jonathan R. Lindner, University of Virginia. Charlottesville, 
VA 
9:30 a.m. 
802-2 Increased Suppression of lntracoronary C-myc Protein 
Synthesis Within the Stent or Balloon Injury Site Using 
an Intravenous Microbubble Delivery System 
Containing Antlsense to C-myc: Comparison With 
Direct lntracoronary Injection 
Thomas R. Porter. Derek Knapp, Lucia Venneri. Joseph Oberdorfer. John Lof, Patrick 
Iversen. Few Xie, University of Nebraska Medical Center, Omaha, NE, AVI BioPharma, 
Inc., Cowallls, OR 
BACKGROUND: Although perlluorocarbon containing albumin microbubbles (PESDA) 
can bind large quantities of antlsense (AS) to the c-myc protooncogene (anti-c-myc) 
which promotes intimal hyperpasia. it is unknown how much c-myc synthesis within the 
intracoronary (IC) stent or balloon injury is actually suppressed by this intravenous (IV) 
targeting technique in the early period following vascular injury. To examine this, we par- 
formed high phase liquid chromatography of AS to c-myc uptake and Western Blot stud- 
ies of c-myc protein synthesis in coronary arteries from eight pigs 90 minutes following IC 
stent and balloon injury (two vessels per pig). Pigs were treated with either direct IC anti- 
c-myc (4 milligrams), or the same dose of anti-c-myc IV bound or unbound to PESDA. IV 
PESDA containing anti-c-myc was given in the presence or absence of transthoracic 1 
megahertz ultrasound (TTU) (pulsed wave at 0.6 W/cm?. RESULTS: C-myc protein syn- 
thesis in the injured coronary arteries (normalized for control vessels) was significantly 
lower when pigs were given IV anti-c-myc bound to PESDA irrespective of whether TTU 
was concomitantly delivered (TABLE). Suppression of c-myc synthesis was comparable 
to direct IC injection. CONCLUSION: These data confirm that simply binding anti-c-myc 
to IV PESDA is a non-invasive method of targeting therapeutic genes to selective sites of 
IC balloon or stent injury and suppressing the formation of the c-myc protooncogene 
which mediates intimal hyperplasia and restenosis. 
*p<O.O5 compared to other groups (ANOVA) 
Background: Identification of tumor angiogenesis could potentially be used for early 
diagnosis of neoplasms and for prognosis. We hypothesized that contrast-enhanced 
ultrasound (CEU) with microbubbles targeted to endothelial qp3 expressed in neoves- 
sels could be used to assess tumor angiogenesis. 
Methods: We created a brain tumor model where I@ U87MG cells derived from a 
human glioblastoma tumor cell line were embedded in gelfoam and injected intracere- 
brally in athymic rats. Tumors were assessed after either 14 or 28 days of growth (n=4 for 
each). Control rats (n=4) were injected with gelfoam alone. Targeted CEU imaging was 
performed 15 min following i.v. injection of control microbubbles (MB) or qpa targeted 
microbubbles (MB,) bearing the disintegrin echistatin on their surface. Cerebral perfu- 
sion was assessed by CEU during continuous infusion of non-targeted microbubbles. A 
corresponding brain slice was processed for immunohistochemistry 
Results: Tumors were -4-fold larger at day 28 compared to day 14 (p.zO.05). Perfusion 
was detected within all tumors and was characterized by low microvascular blood veloc- 
ity. On histology, 15-50 pm neovessels were abundant within the tumor and stained pos- 
itive for endothelial PECAM-1. Dense staining for a& on the endothelium was found 
within tumors, especially at the outer margins. whereas minimal staining was seen in 
control regions. On CEU. M& signal intensity in gelfoam injection sites was low and sim- 
ilar to that in the contralateral hemisphere. At both 14 and 28 days, MB, signal in tumors 
was significantly (p<O.Ol) greater than that for MQ in normal control regions, or for MB 
within the tumor. MBE signal in tumors was greater at 28 versus 14 days (~~0.05). and 
was greatest at the peripheral margins of the tumors. M& intensity within tumors corra- 
lated well with microvascular blood volume derived from CEU perfusion imaging (w0.83, 
P<O.Ol). 
Conclusions: CEU with microbubbles targeted for endothelial a_& can be used to 
assess tumor angiogenesis. These results have impoltant implications for developing 
methods for early detection of primary or metastatic disease, or for developing novel anti- 
neoplastic therapies with microbubble delivery systems. 
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Direct IC AS IV AS/PESDA IV AS/PESDA IV AS +TTU 
+ TTU 
c-myc protein 0.94+0.26 0.88+0.11 0.8920.28 2.1 lr0.28 
ratio 
anh-c-myc 13+16 24+3 312.6 29i38 
Uptake (nanograms) 
802-5 Ultrasound Targeted Microbubble Destruction Can 
Direct Adenoviral or Plasmid Gene Expression to the 
Heart, Pancreas, and Brain 
Raffi H. Bekerediian, Shuyuan Chen, Peter A. Frenkel. Paul A. Grayburn, Ralph V. 
Shohet, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 
9:45 a.m. 
802-3 Improvement in Epicardial Recanalization Rates With 
Transthoracic Therapeutic Ultrasound and Intravenous 
Microbubbles Containing Ligands Which Attach to the 
Glycoprotein Ilb/llla Receptor on Activated Platelets 
Thomas R. Porter, Joseph Oberdorfer. Lucia Venneri, John Lof. Feng Xie, University of 
Nebraska Medical Center, Omaha, NE 
BACKGROUND: Intravenous (IV) perfluorocarbon containing microbubbles (PCMB) and 
transthoracic ultrasound (TrU) could potentially be used to improve epicardial recanali- 
zation rates (ERR) following acute coronary thrombotic occlusion. One limitation with this 
method is that inadequate PCMB reach the occluded coronary thrombus (CT) following 
IV injection. We hypothesized that attaching a ligand to the PCMB which binds to acti- 
vated platelets within the CT would increase microbubble concentration at the site of the 
CT and enhance cavitation-induced lysis. Accordingly, we compared ERR following 
acute left circumflex thrombotic occlusion I” 50 pigs who were randomized to receive 
either IV tissue plasmlnogen activator (TPA) alone, versus IV TPA in combination with 
TTU and unlabelled IV PCMB (PESDA); or TrlJ with IV PCMB containing 50 u/kg of Epti- 
fabitide (E-P&DA). TTU was intermittent 1 Megahertz at 1.5 Watt&+. Recanalization 
was assessed angiographically at 60 minutes following treatment. RESULTS: Activated 
clotting times were not different following any of the treatments. However, the Figure 
demonstrates that ERR mcreased from ~20% with TPA alone to 60% with IV TPA and IV 
E-PESDA combined with TTU. CONCLUSION: These data indicate that IV E-PESDA 
can be used to increase delivery of microbubbles to acute coronary thrombotic occlu- 
sions and improve ultrasound-directed recanalization of the infarct related artery. 
We have previously shown that ultrasound targeted microbubble destruction (UTMD) can 
augment expression of an adenoviral reporter in the heart. We now show that this 
method can selectively deliver transgenes to two organs that are particularly inaccessible 
to non-invasive strategies (pancreas and brain) and can be extended to plasmid vectors. 
Recombinant adenoviruses or plasmids containing expression constructs of beta-galac- 
tosidase and luciferase wars incorporated into albumin-coated perfluoropropane-filled 
microbubbles during their preparation. These bubbles were infused into the internal jugu- 
lar vein of rats and destroyed with ultrasound while passing through the target organ. 
Organs were harvested after 4 days and analyzed for reporter gene activity. Luciferase 
activity in organs targeted with adenovirus was 104 times higher than in control organs. 
However, liver activity was even higher. Histological examination revealed transgene- 
derived beta-galactosidase activity in subsets of brain neurons and pancreatic islets. 
Luciferase transfection with plasmids showed highly specific gene expression in the 
heart, lo-fold lower than obtained with adenovirus, but with negligible activity in liver (fig- 
ure). We conclude that ultrasound targeted microbubble destruction can markedly 
Improve the range and specificity of gene delivery. This technique heralds a new class of 
strategies for non-invasive gene therapy 
